NO3043778T3 - - Google Patents
Info
- Publication number
- NO3043778T3 NO3043778T3 NO14766156A NO14766156A NO3043778T3 NO 3043778 T3 NO3043778 T3 NO 3043778T3 NO 14766156 A NO14766156 A NO 14766156A NO 14766156 A NO14766156 A NO 14766156A NO 3043778 T3 NO3043778 T3 NO 3043778T3
- Authority
- NO
- Norway
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2893—Tablet coating processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13184229.6A EP2848246A1 (en) | 2013-09-13 | 2013-09-13 | Pharmaceutical compositions containing refametinib |
| EP13184539 | 2013-09-16 | ||
| EP14766156.5A EP3043778B1 (en) | 2013-09-13 | 2014-09-11 | Pharmaceutical compositions containing refametinib |
| PCT/EP2014/069453 WO2015036512A1 (en) | 2013-09-13 | 2014-09-11 | Pharmaceutical compositions containing refametinib |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO3043778T3 true NO3043778T3 (no) | 2018-02-03 |
Family
ID=51541077
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO14766156A NO3043778T3 (no) | 2013-09-13 | 2014-09-11 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20160220494A1 (no) |
| EP (1) | EP3043778B1 (no) |
| JP (1) | JP2016531151A (no) |
| CN (1) | CN105658209A (no) |
| CA (1) | CA2923990A1 (no) |
| DK (1) | DK3043778T3 (no) |
| ES (1) | ES2648267T3 (no) |
| HU (1) | HUE035877T2 (no) |
| NO (1) | NO3043778T3 (no) |
| PL (1) | PL3043778T3 (no) |
| TW (1) | TW201542245A (no) |
| UY (1) | UY35734A (no) |
| WO (1) | WO2015036512A1 (no) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10058630B2 (en) | 2012-10-22 | 2018-08-28 | Concievalve, Llc | Methods for inhibiting stenosis, obstruction, or calcification of a stented heart valve or bioprosthesis |
| RU2015147696A (ru) | 2013-04-09 | 2017-05-12 | Бостон Байомедикал, Инк. | Способы лечения злокачественной опухоли |
| LT3105218T (lt) | 2014-02-13 | 2019-12-10 | Incyte Corp | Ciklopropilaminai kaip lsd1 inhibitoriai |
| HUE045725T2 (hu) | 2014-02-13 | 2020-01-28 | Incyte Corp | Ciklopropilaminok mint LSD1 inhibitorok |
| US9695167B2 (en) | 2014-07-10 | 2017-07-04 | Incyte Corporation | Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitors |
| MA51438A (fr) | 2015-04-03 | 2021-04-14 | Incyte Corp | Composés hétérocycliques utilisés en tant qu'inhibiteurs de lsd1 |
| MX2018001706A (es) | 2015-08-12 | 2018-09-06 | Incyte Corp | Sales de un inhibidor de dimetilasa 1 especifica para lisina (lsd1). |
| US9724393B2 (en) | 2015-10-06 | 2017-08-08 | The Wistar Institute Of Anatomy And Biology | Method for treatment of metastatic and refractory cancers and tumors with an inducer that overcomes inhibition of T cell proliferation |
| CN107224438B (zh) * | 2016-03-25 | 2021-04-06 | 江苏豪森药业集团有限公司 | 富马酸沃诺拉赞药物组合物 |
| KR101796684B1 (ko) * | 2016-05-19 | 2017-11-10 | 건국대학교 산학협력단 | 케라틴 8 인산화 억제제를 포함하는 황반변성 예방 또는 치료용 약학 조성물 및 황반변성 치료제의 스크리닝 방법 |
| US11299469B2 (en) | 2016-11-29 | 2022-04-12 | Sumitomo Dainippon Pharma Oncology, Inc. | Naphthofuran derivatives, preparation, and methods of use thereof |
| CA3058162A1 (en) * | 2017-03-30 | 2018-10-04 | Boston Biomedical, Inc. | Compositions for treating and/or preventing cancer |
| US10646464B2 (en) | 2017-05-17 | 2020-05-12 | Boston Biomedical, Inc. | Methods for treating cancer |
| JP7166754B2 (ja) * | 2017-11-22 | 2022-11-08 | 沢井製薬株式会社 | ダサチニブ無水物含有製剤 |
| WO2020047198A1 (en) | 2018-08-31 | 2020-03-05 | Incyte Corporation | Salts of an lsd1 inhibitor and processes for preparing the same |
| CN115487186B (zh) * | 2022-09-29 | 2024-04-16 | 北京朗瑞邦科技有限公司 | 一种具有mTOR抑制活性的药物制剂及其制备方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ297271B6 (cs) * | 1994-07-12 | 2006-10-11 | Bpsi Holdings, Inc. | Suchá povlaková hmota pro výrobu filmu zabranujícímu prístupu vlhkosti, zpusob a tvorba povlaku |
| CR5278A (es) * | 1995-03-24 | 1996-07-04 | Lilly Co Eli | Formulacion oral de 2-metil-tieno-benzodiacepina |
| US6448323B1 (en) * | 1999-07-09 | 2002-09-10 | Bpsi Holdings, Inc. | Film coatings and film coating compositions based on polyvinyl alcohol |
| SE0201110D0 (sv) * | 2002-04-12 | 2002-04-12 | Astrazeneca Ab | New film coating |
| PA8576201A1 (es) * | 2002-07-10 | 2004-05-26 | Pfizer Prod Inc | Composicion farmaceutica que tiene una distribucion y potencia uniforme de farmaco |
| JP2004051506A (ja) * | 2002-07-17 | 2004-02-19 | Nichiko Pharmaceutical Co Ltd | 経時的な変色を抑制した医薬組成物 |
| JP2004300138A (ja) * | 2003-03-18 | 2004-10-28 | Takeda Chem Ind Ltd | 安定化された経口固形製剤 |
| CA2694646C (en) * | 2007-07-30 | 2017-09-05 | Ardea Biosciences, Inc. | Combinations of mek inhibitors and raf kinase inhibitors and uses thereof |
| KR20110014149A (ko) * | 2008-04-14 | 2011-02-10 | 아디아 바이오사이언스즈 인크. | 조성물 및 이것의 제조 및 사용 방법 |
| DE102008059206A1 (de) * | 2008-11-27 | 2010-06-10 | Bayer Schering Pharma Aktiengesellschaft | Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum |
| CN103948600A (zh) * | 2009-03-11 | 2014-07-30 | 阿迪生物科学公司 | 用于治疗特定癌症的包含rdea119/bay869766的药物组合 |
| JP2011162531A (ja) * | 2010-02-10 | 2011-08-25 | Takada Seiyaku Kk | フェキソフェナジン含有フイルムコーテイング経口製剤 |
| JP5700367B2 (ja) * | 2010-05-06 | 2015-04-15 | 高田製薬株式会社 | パロキセチン含有フイルムコ−テイング経口製剤 |
| WO2012120364A2 (en) * | 2011-03-09 | 2012-09-13 | Ideal Cures Pvt. Ltd. | Novel immediate release film coating compositions |
| UY35006A (es) * | 2012-09-06 | 2014-03-31 | Bayer Healthcare Llc | Composición farmacéutica recubierta que contiene regorafenib |
-
2014
- 2014-09-11 CA CA2923990A patent/CA2923990A1/en not_active Abandoned
- 2014-09-11 CN CN201480059238.XA patent/CN105658209A/zh active Pending
- 2014-09-11 DK DK14766156.5T patent/DK3043778T3/da active
- 2014-09-11 NO NO14766156A patent/NO3043778T3/no unknown
- 2014-09-11 PL PL14766156T patent/PL3043778T3/pl unknown
- 2014-09-11 JP JP2016542319A patent/JP2016531151A/ja active Pending
- 2014-09-11 ES ES14766156.5T patent/ES2648267T3/es active Active
- 2014-09-11 HU HUE14766156A patent/HUE035877T2/en unknown
- 2014-09-11 WO PCT/EP2014/069453 patent/WO2015036512A1/en active Application Filing
- 2014-09-11 EP EP14766156.5A patent/EP3043778B1/en not_active Not-in-force
- 2014-09-11 US US15/021,778 patent/US20160220494A1/en not_active Abandoned
- 2014-09-12 UY UY0001035734A patent/UY35734A/es not_active Application Discontinuation
- 2014-09-12 TW TW103131660A patent/TW201542245A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2648267T3 (es) | 2017-12-29 |
| CA2923990A1 (en) | 2015-03-19 |
| PL3043778T3 (pl) | 2018-04-30 |
| EP3043778B1 (en) | 2017-09-06 |
| WO2015036512A1 (en) | 2015-03-19 |
| CN105658209A (zh) | 2016-06-08 |
| TW201542245A (zh) | 2015-11-16 |
| EP3043778A1 (en) | 2016-07-20 |
| US20160220494A1 (en) | 2016-08-04 |
| JP2016531151A (ja) | 2016-10-06 |
| DK3043778T3 (da) | 2017-11-27 |
| HUE035877T2 (en) | 2018-05-28 |
| UY35734A (es) | 2015-04-30 |